2015
DOI: 10.1016/j.ijcard.2015.01.085
|View full text |Cite
|
Sign up to set email alerts
|

Presence of myocardial hypoenhancement on multidetector computed tomography after primary percutaneous coronary intervention in acute myocardial infarction predicts poor prognosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 33 publications
0
3
0
Order By: Relevance
“…It has been shown that 65% of patients with acute STEMI still had microvascular obstruction following advanced percutaneous coronary procedures (18). The results of the cardiovascular magnetic resonance survey showed that microvascular obstruction was associated with a larger infarct size (19) and a poorer prognosis (20), confirming the close link between infarct size and microvascular obstruction.…”
Section: Enhancing the Microcirculation By Using Better Techniquesmentioning
confidence: 92%
“…It has been shown that 65% of patients with acute STEMI still had microvascular obstruction following advanced percutaneous coronary procedures (18). The results of the cardiovascular magnetic resonance survey showed that microvascular obstruction was associated with a larger infarct size (19) and a poorer prognosis (20), confirming the close link between infarct size and microvascular obstruction.…”
Section: Enhancing the Microcirculation By Using Better Techniquesmentioning
confidence: 92%
“…MDCT performed immediately after PPCI could detect hypo-enhanced areas that were significantly associated with coronary angiographic no-reflow. 78 MDCT performed without contrast reinjection immediately after PPCI for the identification of heterogeneous enhancement could also predict the occurrence of MVO and adverse LV remodeling by CMR. 79 This approach is logistically difficult to implement in most centers.…”
Section: Msctmentioning
confidence: 99%
“…By injecting CM into the thoracic aorta, we emulate percutaneous cardiac interventions. The CM dose used is in the lower range of the doses patients undergoing such interventions usually receive [49][50][51][52], as compared on a per body surface area basis as required for dose-dependent adverse effects between species by regulatory bodies [50]. However, during cardiac interventions the CM is usually given by consecutive smaller injections.…”
Section: Issn: 2380-0585mentioning
confidence: 99%